RE:RE:RE:Global cannabis pharmaceutical outlookI think the FDA would disagree with your comment of their research not being precise because the NIH is using product from LABS for clinical trials and the FDA also approved their facility. I disagree with your comments w.r.t. NDA submission because that submission was executed in conjunction with their yet to be named global pharmaceutical partner and proof of that is that no record within the FDA associates that NDA with the name of Medipharm Labs. The only association found with Medipharm Labs is simply their DMF submission.
Be patient, Pfizer will step out soon enough.